This page in English

Joakim Dillner

Professor

Besöksadress : F56, Karolinska Universitetssjukhuset 14186 Stockholm
Postadress : Institutionen för laboratoriemedicin (LABMED), H5, Avdelningen för patologi, F46, Karolinska Universitetssjukhuset, Huddinge 141 86 Stockholm
Leveransadress : F56 Via Varumottagningen, Karolinska Universitetssjukhuset 14186 Stockholm

Om mig

Jag är professor i infektionsepidemiologi sedan 2009. Jag började forska inom ämnet tumörvirologi 1982 i George Kleins grupp rörande Epstein-Barr virus och blev professor i virologi 2001. Sen 1989 har min grupp bedrivit forskning om Humant Papillomvirus (HPV) inom molekylärbiologi, immunologi och vaccinologi, klinisk virologi och epidemiologi. Stora pågående projekt är Swedescreen, den första randomiserade HPV-screeningsstudien (sedan 1997), biobank- och registerbaserade uppföljningsstudier av HPV vaccination (sedan 1999), det Internationella Referenscentret för Papillomvirus (www.hpvcenter.se), Nationellt Kvalitetsregister för Cervixcancerprevention (www.nkcx.se), Nordiska Ministerrådets Excellenscentrum inom eHälsa (www.nordicehealth.se) och EUs excellensprojekt in jämförande vårdeffektivitetsforskning (CoHeaHr).

 

 

 

Utbildning

  • Forskarutbildning vid Karolinska Institutet.  Disputerade 1986 med avhandlingen ”Identification and Characterization of Epstein-Barr Virus Encoded Proteins in EBV-transformed cells”
  • Läkarexamen vid Karolinska Institutet, 1981-1995
  • Post-doc 1986-1988 vid Scripps Clinic, La Jolla, Kalifornien
  • Docent i virologi, Karolinska Institutet, 1990

Forskningsbeskrivning

Min forskning fokuserar på cancerscreening och tumörvirologi, i synnerhet Humant Papillomvirus (HPV). Exempel på projekt är prövningar om användning av HPV-testning inom det gynekologiska cellprovtagningsprogrammet, nordiska uppföljningsstudier om HPV vaccination samt internationella molekylärepidemiologiska studier av infektioners roll för canceruppkomst. Målet med min forskning är att genom att främja utbyggnad och länkning av högkvalitativ forskningsinfrastruktur som kohorter, biobanker och register kunna utveckla effektivare program för förebyggande av cancer.

Akademiska priser och utmärkelser

  • Ledamot av Cancerfondens Forskningsnämnd 2009-2015
  • Ordförande, Nationellt Kvalitetsregister för Cervixcancerprevention

Dokument

Länkar

Publikationer

Bereavement Is Associated with an Increased Risk of HPV Infection and Cervical Cancer: An Epidemiological Study in Sweden
Lu D, Sundstrom K, Sparen P, Fall K, Sjolander A, Dillner J, et al
Cancer research 2016;76(3):643-51

Cutaneous Human Papillomaviruses and Squamous Cell Carcinoma of the Skin: Nested Case-Control Study
Faust H, Andersson K, Luostarinen T, Gislefoss Re, Dillner J
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016;25(4):721-4

HPV-FASTER: broadening the scope for prevention of HPV-related cancer
Bosch Fx, Robles C, Diaz M, Arbyn M, Baussano I, Clavel C, et al
Nature reviews. Clinical oncology 2016;13(2):119-32

Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs
Elfstrom Km, Lazzarato F, Franceschi S, Dillner J, Baussano I
The Journal of infectious diseases 2016;213(2):199-205

Laboratory audit as part of the quality assessment of a primary HPV-screening program
Hortlund M, Sundstrom K, Lamin H, Hjerpe A, Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2016;75():33-6

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study
Wang J, Andrae B, Sundstrom K, Strom P, Ploner A, Elfstrom Km, et al
BMJ (Clinical research ed.) 2016;352():i276-

Sourcing of the WHO human papillomavirus type 18 international standards for HPV antibody levels
Faust H, Eklund C, Sukvirach S, Ngamkham J, Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2016;78():89-92

The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort
Roura E, Travier N, Waterboer T, De Sanjose S, Bosch Fx, Pawlita M, et al
PloS one 2016;11(1):e0147029-

Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort
Roura E, Travier N, Waterboer T, De Sanjose S, Bosch Fx, Pawlita M, et al
PloS one 2016;11(3):e0151427-

Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion
Rossi Pg, Ronco G, Dillner J, Elfstrom Km, Snijders Pj, Arbyn M, et al
Cancer cytopathology 2016;124(1):66-7

Viremia during pregnancy and risk of childhood leukemia and lymphomas in the offspring: Nested case-control study
Bzhalava D, Hultin E, Arroyo Muhr Ls, Ekstrom J, Lehtinen M, De Villiers Em, et al
International journal of cancer 2016;138(9):2212-20

A basis for translational cancer research on aetiology, pathogenesis and prognosis: Guideline for standardised and population-based linkages of biobanks to cancer registries
Dillner J
European journal of cancer (Oxford, England : 1990) 2015;51(9):1018-27

Cervical cancer screening in Europe: Quality assurance and organisation of programmes
Elfstrom Km, Arnheim-dahlstrom L, Von Karsa L, Dillner J
European journal of cancer (Oxford, England : 1990) 2015;51(8):950-68

Clinical trials of human papillomavirus vaccines and beyond (vol 10, pg 400, 2013)
Lehtinen M, Dillner J
NATURE REVIEWS CLINICAL ONCOLOGY 2015;12(1):2-2

Does human papillomavirus-negative condylomata exist?
Arroyo Muhr Ls, Bzhalava D, Lagheden C, Eklund C, Johansson H, Forslund O, et al
Virology 2015;485():283-8

European Code against Cancer 4th Edition: Infections and Cancer
Villain P, Gonzalez P, Almonte M, Franceschi S, Dillner J, Anttila A, et al
Cancer epidemiology 2015;39 Suppl 1():S120-38

Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening
Soderlund-strand A, Wikstrom A, Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2015;64():88-91

Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine
Nygard M, Saah A, Munk C, Tryggvadottir L, Enerly E, Hortlund M, et al
Clinical and vaccine immunology : CVI 2015;22(8):943-8

Fewer than three doses of HPV vaccine
Lehtinen M, Dillner J
The Lancet. Oncology 2015;16(9):e422-3

Fewer than three doses of HPV vaccine
Lehtinen M, Dillner J
LANCET ONCOLOGY 2015;16(9):E422-E423

Human papillomavirus type 197 is commonly present in skin tumors
Arroyo Muhr Ls, Hultin E, Bzhalava D, Eklund C, Lagheden C, Ekstrom J, et al
International journal of cancer 2015;136(11):2546-55

Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer
Sundstrom K, Ploner A, Arnheim-dahlstrom L, Eloranta S, Palmgren J, Adami Ho, et al
Journal of the National Cancer Institute 2015;107(10):-

International standardization and classification of human papillomavirus types
Bzhalava D, Eklund C, Dillner J
Virology 2015;476():341-4

Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial
Elfstrom Km, Smelov V, Johansson Al, Eklund C, Naucler P, Arnheim-dahlstrom L, et al
International journal of cancer 2015;136(2):350-9

Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial
Smelov V, Elfstrom Km, Johansson Al, Eklund C, Naucler P, Arnheim-dahlstrom L, et al
International journal of cancer 2015;136(5):1171-80

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
Persson M, Elfstrom Km, Olsson Se, Dillner J, Andersson S
PloS one 2015;10(6):e0127444-

Molecular methods for identification and characterization of novel papillomaviruses
Kocjan Bj, Bzhalava D, Forslund O, Dillner J, Poljak M
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015;21(9):808-16

Near full control of human papillomavirus vaccine types
Dillner J
The Lancet. Infectious diseases 2015;15(11):1251-2

Organization and quality of HPV vaccination programs in Europe
Elfstrom Km, Dillner J, Arnheim-dahlstrom L
Vaccine 2015;33(14):1673-81

Prevention of human papillomavirus-associated cancers
Dillner J
Seminars in oncology 2015;42(2):272-83

Sakkunniga: God evidens for screeningrekommendationer.
Strander B, Dillner J, Adolfsson J, Larsson Lt
Läkartidningen 2015;112():-

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study
Herweijer E, Feldman Al, Ploner A, Arnheim-dahlstrom L, Uhnoo I, Netterlid E, et al
PloS one 2015;10(7):e0134185-

The process of moving from a regionally based cervical cytology biobank to a national infrastructure
Perskvist N, Norlin L, Dillner J
Biopreservation and biobanking 2015;13(2):94-7

Translational cancer research: balancing prevention and treatment to combat cancer globally
Wild Cp, Bucher Jr, De Jong Bw, Dillner J, Von Gertten C, Groopman Jd, et al
Journal of the National Cancer Institute 2015;107(1):353-

A complex intervention for workflow enhancement at the Swedish cervical cytology biobank
Perskvist N, Bjorklund C, Dillner J
Biopreservation and biobanking 2014;12(1):69-73

Are 20 human papillomavirus types causing cervical cancer?
Arbyn M, Tommasino M, Depuydt C, Dillner J
The Journal of pathology 2014;234(4):431-5

Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma
Herweijer E, Leval A, Ploner A, Eloranta S, Simard Jf, Dillner J, et al
JAMA 2014;311(6):597-603

Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study
Soderlund-strand A, Uhnoo I, Dillner J
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014;23(12):2757-64

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
Nygard M, Roysland K, Campbell S, Dillner J
BMJ open 2014;4(1):e003460-

Deep sequencing extends the diversity of human papillomaviruses in human skin
Bzhalava D, Muhr Ls, Lagheden C, Ekstrom J, Forslund O, Dillner J, et al
Scientific reports 2014;4():5807-

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Ronco G, Dillner J, Elfstrom Km, Tunesi S, Snijders Pj, Arbyn M, et al
Lancet (London, England) 2014;383(9916):524-32

Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study
Eklund C, Forslund O, Wallin Kl, Dillner J
Journal of clinical microbiology 2014;52(2):449-59

HPV-based screening for prevention of invasive cervical cancer - Authors' reply
Ronco G, Meijer Cj, Segnan N, Kitchener H, Giorgi-rossi P, Peto J, et al
Lancet (London, England) 2014;383(9925):1295-

Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia
Soderlund-strand A, Kjellberg L, Dillner J
Journal of medical virology 2014;86(4):634-41

Infrastructure and facilities for human biobanking in low- and middle-income countries: a situation analysis
Mendy M, Caboux E, Sylla Bs, Dillner J, Chinquee J, Wild C, et al
Pathobiology : journal of immunopathology, molecular and cellular biology 2014;81(5-6):252-60

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
Elfstrom Km, Smelov V, Johansson Al, Eklund C, Naucler P, Arnheim-dahlstrom L, et al
BMJ (Clinical research ed.) 2014;348():g130-

Metagenomic sequencing of expressed prostate secretions
Smelov V, Arroyo Muhr Ls, Bzhalava D, Brown Lj, Komyakov B, Dillner J
Journal of medical virology 2014;86(12):2042-8

Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort
Castellsague X, Pawlita M, Roura E, Margall N, Waterboer T, Bosch Fx, et al
International journal of cancer 2014;135(2):440-52

Prospective study of Merkel cell polyomavirus and risk of Merkel cell carcinoma
Faust H, Andersson K, Ekstrom J, Hortlund M, Robsahm Te, Dillner J
International journal of cancer 2014;134(4):844-8

Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia
Omland T, Lie Ka, Akre H, Sandlie Le, Jebsen P, Sandvik L, et al
PloS one 2014;9(6):e99114-

Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort
Roura E, Castellsague X, Pawlita M, Travier N, Waterboer T, Margall N, et al
International journal of cancer 2014;135(2):453-66

Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance
Nygard M, Hansen Bt, Dillner J, Munk C, Oddsson K, Tryggvadottir L, et al
PloS one 2014;9(2):e88323-

Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model
Baussano I, Dillner J, Lazzarato F, Ronco G, Franceschi S
Infectious agents and cancer 2014;9(1):4-

Absence of Epstein-Barr and cytomegalovirus infection in neuroblastoma cells by standard detection methodologies
Sehic D, Forslund O, Sanden E, Mengelbier Lh, Karlsson J, Bzhalava D, et al
Pediatric blood & cancer 2013;60(9):E91-3

Are human papillomavirus DNA prevalences providing high-flying estimates of infection? An international survey of HPV detection on environmental surfaces
Smelov V, Eklund C, Arroyo Muhr Ls, Hultin E, Dillner J
Sexually transmitted infections 2013;89(8):627-

A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types
Bzhalava D, Guan P, Franceschi S, Dillner J, Clifford G
Virology 2013;445(1-2):224-31

Benefits of catch-up in vaccination against human papillomavirus in medium- and low-income countries
Baussano I, Lazzarato F, Ronco G, Dillner J, Franceschi S
International journal of cancer 2013;133(8):1876-81

Clinical trials of human papillomavirus vaccines and beyond
Lehtinen M, Dillner J
Nature reviews. Clinical oncology 2013;10(7):400-10

Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening
Darlin L, Borgfeldt C, Forslund O, Henic E, Hortlund M, Dillner J, et al
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013;58(1):155-60

Diversity of human papillomaviruses in skin lesions
Ekstrom J, Muhr Ls, Bzhalava D, Soderlund-strand A, Hultin E, Nordin P, et al
Virology 2013;447(1-2):300-11

Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses
Schellenbacher C, Kwak K, Fink D, Shafti-keramat S, Huber B, Jindra C, et al
The Journal of investigative dermatology 2013;133(12):2706-13

Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination
Tota Je, Ramanakumar Av, Jiang M, Dillner J, Walter Sd, Kaufman Js, et al
American journal of epidemiology 2013;178(4):625-34

[Evaluable implementation of HPV testing]
Dillner J, Elfgren K, Tornberg S
Läkartidningen 2013;110(23-24):1169-70

Expressed prostate secretions in the study of human papillomavirus epidemiology in the male
Smelov V, Eklund C, Bzhalava D, Novikov A, Dillner J
PloS one 2013;8(6):e66630-

False-positive prostate cancer markers in a man with symptomatic urethral Chlamydia trachomatis infection
Smelov V, Novikov A, Brown Lj, Eklund C, Strokova L, Ouburg S, et al
International journal of STD & AIDS 2013;24(6):501-2

High-throughput monitoring of human papillomavirus type distribution
Soderlund-strand A, Dillner J
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013;22(2):242-50

Human papillomavirus typing in reporting of condyloma
Sturegard E, Johansson H, Ekstrom J, Hansson Bg, Johnsson A, Gustafsson E, et al
Sexually transmitted diseases 2013;40(2):123-9

Metagenomic sequencing of "HPV-negative" condylomas detects novel putative HPV types
Johansson H, Bzhalava D, Ekstrom J, Hultin E, Dillner J, Forslund O
Virology 2013;440(1):1-7

Mutations in human papillomavirus type 16 L1 hypervariable surface-exposed loops affect L2 binding and DNA encapsidation
Faust H, Dillner J
The Journal of general virology 2013;94(Pt 8):1841-9

Next generation sequencing for human papillomavirus genotyping
Arroyo Ls, Smelov V, Bzhalava D, Eklund C, Hultin E, Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013;58(2):437-42

Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study
Luostarinen T, Namujju Pb, Merikukka M, Dillner J, Hakulinen T, Koskela P, et al
International journal of cancer 2013;133(7):1756-9

Patients would benefit from simplified ethical review and consent procedure
Hansson Mg, Van Ommen Gj, Chadwick R, Dillner J
The Lancet. Oncology 2013;14(6):451-3

Patterns of human papillomavirus types in multiple infections: an analysis in women and men of the high throughput human papillomavirus monitoring study
Vaccarella S, Soderlund-strand A, Franceschi S, Plummer M, Dillner J
PloS one 2013;8(8):e71617-

Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program
Ucakar V, Jelen Mm, Faust H, Poljak M, Dillner J, Klavs I
Vaccine 2013;31(43):4935-9

Primary human papillomavirus testing in organized cervical screening
Dillner J
Current opinion in obstetrics & gynecology 2013;25(1):11-6

Prospective study of genital human papillomaviruses and nonmelanoma skin cancer
Andersson K, Luostarinen T, Strand As, Langseth H, Gislefoss Re, Forslund O, et al
International journal of cancer 2013;133(8):1840-5

Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer
Sundstrom K, Ploner A, Dahlstrom La, Palmgren J, Dillner J, Adami Ho, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013;22(1):150-8

Pseudovirion-binding and neutralizing antibodies to cutaneous human papillomaviruses (HPV) correlated with the presence of HPV DNA in skin
Faust H, Andersson K, Forslund O, Dillner J
The Journal of general virology 2013;94(Pt 5):1096-103

Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study
Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, et al
Journal of the National Cancer Institute 2013;105(7):469-74

Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types
Faust H, Jelen Mm, Poljak M, Klavs I, Ucakar V, Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013;56(4):336-41

The Swedish cervical cytology biobank: sample handling and storage process
Perskvist N, Norman I, Eklund C, Litton Je, Dillner J
Biopreservation and biobanking 2013;11(1):19-24

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
Leinonen Mk, Anttila A, Malila N, Dillner J, Forslund O, Nieminen P
British journal of cancer 2013;109(11):2941-50

Type-specific human papillomavirus biological features: validated model-based estimates
Baussano I, Elfstrom Km, Lazzarato F, Gillio-tos A, De Marco L, Carozzi F, et al
PloS one 2013;8(11):e81171-

Unbiased approach for virus detection in skin lesions
Bzhalava D, Johansson H, Ekstrom J, Faust H, Moller B, Eklund C, et al
PloS one 2013;8(6):e65953-

Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity
Darlin L, Borgfeldt C, Forslund O, Henic E, Dillner J, Kannisto P
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013;56(1):52-6

Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity (vol 56, pg 52, 2013)
Darlin L, Borgfeldt C, Forslund O, Henic E, Dillner J, Kannisto P
JOURNAL OF CLINICAL VIROLOGY 2013;58(3):600-600

A nested case-control study of intrauterine exposure to persistent organochlorine pollutants and the risk of hypospadias
Rignell-hydbom A, Lindh Ch, Dillner J, Jonsson Ba, Rylander L
PloS one 2012;7(9):e44767-

Combined effect of low-penetrant SNPs on breast cancer risk
Harlid S, Ivarsson Mi, Butt S, Grzybowska E, Eyfjord Je, Lenner P, et al
British journal of cancer 2012;106(2):389-96

Decline of the new Swedish variant of Chlamydia trachomatis after introduction of appropriate testing
Persson K, Hammas B, Janson H, Bjartling C, Dillner J, Dillner L
Sexually transmitted infections 2012;88(6):451-5

Genetic predisposition, parity, age at first childbirth and risk for breast cancer
Butt S, Harlid S, Borgquist S, Ivarsson M, Landberg G, Dillner J, et al
BMC research notes 2012;5():414-

Human papillomavirus antibody reference reagents for use in postvaccination surveillance serology
Bissett Sl, Wilkinson D, Tettmar Ki, Jones N, Stanford E, Panicker G, et al
Clinical and vaccine immunology : CVI 2012;19(3):449-51

Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer
Harlid S, Butt S, Ivarsson Mi, Eyfjord Je, Lenner P, Manjer J, et al
BMC women's health 2012;12():17-

International collaborative proficiency study of Human Papillomavirus type 16 serology
Eklund C, Unger Er, Nardelli-haefliger D, Zhou T, Dillner J
Vaccine 2012;30(2):294-9

No evidence of enteroviruses in the intestine of patients with type 1 diabetes
Mercalli A, Lampasona V, Klingel K, Albarello L, Lombardoni C, Ekstrom J, et al
Diabetologia 2012;55(9):2479-88

Nucleic acid tests for the detection of alpha human papillomaviruses
Poljak M, Cuzick J, Kocjan Bj, Iftner T, Dillner J, Arbyn M
Vaccine 2012;30 Suppl 5():F100-6

Performance of commercial reverse line blot assays for human papillomavirus genotyping
Steinau M, Onyekwuluje Jm, Scarbrough Mz, Unger Er, Dillner J, Zhou T
Journal of clinical microbiology 2012;50(5):1539-44

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
De Kok Im, Van Rosmalen J, Dillner J, Arbyn M, Sasieni P, Iftner T, et al
BMJ (Clinical research ed.) 2012;344():e670-

Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer
Andersson K, Michael Km, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, et al
American journal of epidemiology 2012;175(7):685-95

Randomised health services studies
Hakama M, Malila N, Dillner J
International journal of cancer 2012;131(12):2898-902

Screening and cervical cancer cure: population based cohort study
Andrae B, Andersson Tm, Lambert Pc, Kemetli L, Silfverdal L, Strander B, et al
BMJ (Clinical research ed.) 2012;344():e900-

Screening for cervical cancer
Ronco G, Meijer Cj, Cuzick J, Giorgi-rossi P, Peto J, Segnan N, et al
Annals of internal medicine 2012;156(8):604-5

The 2010 global proficiency study of human papillomavirus genotyping in vaccinology
Eklund C, Forslund O, Wallin Kl, Zhou T, Dillner J, Who Human Papillomavirus Laboratory Network
Journal of clinical microbiology 2012;50(7):2289-98

A broad-spectrum Human Papillomavirus (HPV) vaccine to prevent mucosal and cutaneous HPV infections
Schellenbacher C, Kwak K, Shafti-keramat S, Faust H, Dillner J, Roden R, et al
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2011;:S99-S99

A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP
Harlid S, Ivarsson Mi, Butt S, Hussain S, Grzybowska E, Eyfjord Je, et al
International journal of cancer 2011;129(7):1689-98

Antibodies to Merkel cell polyomavirus correlate to presence of viral DNA in the skin
Faust H, Pastrana Dv, Buck Cb, Dillner J, Ekstrom J
The Journal of infectious diseases 2011;203(8):1096-100

Biobanks collected for routine healthcare purposes: build-up and use for epidemiologic research
Dillner J, Andersson K
Methods in molecular biology (Clifton, N.J.) 2011;675():113-25

Cervical cytology biobanks as a resource for molecular epidemiology
Arbyn M, Andersson K, Bergeron C, Bogers Jp, Von Knebel-doebertitz M, Dillner J
Methods in molecular biology (Clifton, N.J.) 2011;675():279-98

Characterization of the complete genomes of Camelus dromedarius papillomavirus types 1 and 2
Ure Ae, Elfadl Ak, Khalafalla Ai, Gameel Aa, Dillner J, Forslund O
The Journal of general virology 2011;92(Pt 8):1769-77

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
Lehtinen M, Ault Ka, Lyytikainen E, Dillner J, Garland Sm, Ferris Dg, et al
Sexually transmitted infections 2011;87(5):372-6

Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study
Gonzalez Ca, Travier N, Lujan-barroso L, Castellsague X, Bosch Fx, Roura E, et al
International journal of cancer 2011;129(2):449-59

Endogenous sex steroids and risk of cervical carcinoma: results from the EPIC study
Rinaldi S, Plummer M, Biessy C, Castellsague X, Overvad K, Kruger Kjaer S, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(12):2532-40

Genotyping of human papillomavirus in triaging of low-grade cervical cytology
Soderlund-strand A, Eklund C, Kemetli L, Grillner L, Tornberg S, Dillner J, et al
American journal of obstetrics and gynecology 2011;205(2):145.e1-6

High throughput sequencing reveals diversity of Human Papillomaviruses in cutaneous lesions
Ekstrom J, Bzhalava D, Svenback D, Forslund O, Dillner J
International journal of cancer 2011;129(11):2643-50

H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship?
Persson C, Jia Y, Pettersson H, Dillner J, Nyren O, Ye W
PloS one 2011;6(3):e17404-

Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control study
Naucler P, Mabota Da Costa F, Da Costa Jl, Ljungberg O, Bugalho A, Dillner J
The Journal of general virology 2011;92(Pt 12):2784-91

Monitoring of human papillomavirus vaccination
Dillner J, Arbyn M, Unger E, Dillner L
Clinical and experimental immunology 2011;163(1):17-25

Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters
Okroj M, Tedeschi R, Mancuso R, Brambilla L, Tourlaki A, Dillner J, et al
Vaccine 2011;29(6):1129-34

Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters
Okroj M, Tedeschi R, Mancuso R, Brambilla L, Tourlaki A, Dillner J, et al
MOLECULAR IMMUNOLOGY 2011;48(14):1716-1716

Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer
Arnheim Dahlstrom L, Andersson K, Luostarinen T, Thoresen S, Ogmundsdottir H, Tryggvadottir L, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(12):2541-50

Randomized healthservices study of human papillomavirus-based management of low-grade cytological abnormalities
Dillner L, Kemetli L, Elfgren K, Bogdanovic G, Andersson P, Carlsten-thor A, et al
International journal of cancer 2011;129(1):151-9

Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control study
Silfverdal L, Kemetli L, Sparen P, Andrae B, Strander B, Ryd W, et al
International journal of cancer 2011;129(6):1450-8

Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia
Bzhalava D, Bray F, Storm H, Dillner J
British journal of cancer 2011;104(1):178-80

Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers
Lindehammer Sr, Hansson I, Midberg B, Ivarsson Sa, Lynch Kf, Dillner J, et al
Journal of reproductive immunology 2011;88(1):72-9

A summary of the 25th International Papillomavirus Conference 2009: vaccines, screening, epidemiology and therapeutics
Nicol Af, Nuovo Gj, Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2010;47(3):208-15

Cervical cytology biobanking in Europe
Arbyn M, Van Veen Eb, Andersson K, Bogers J, Boulet G, Bergeron C, et al
The International journal of biological markers 2010;25(3):117-25

Ensuring quality in studies linking cancer registries and biobanks
Langseth H, Luostarinen T, Bray F, Dillner J
Acta oncologica (Stockholm, Sweden) 2010;49(3):368-77

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Future I/ii Study Group, Dillner J, Kjaer Sk, Wheeler Cm, Sigurdsson K, Iversen Oe, et al
BMJ (Clinical research ed.) 2010;341():c3493-

Global proficiency study of human papillomavirus genotyping
Eklund C, Zhou T, Dillner J, Who Human Papillomavirus Laboratory Network
Journal of clinical microbiology 2010;48(11):4147-55

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women
Munoz N, Kjaer Sk, Sigurdsson K, Iversen Oe, Hernandez-avila M, Wheeler Cm, et al
Journal of the National Cancer Institute 2010;102(5):325-39

Induction of Broadly Cross-neutralizing Antisera against Mucosal and Cutaneous Human Papillomayiruses (HPV) by HPV16L1-16L2 Virus-like Particles (RG1-VLP)
Schellenbacher C, Shafti-keramat S, Faust H, Dillner J, Roden R, Kimbauer R
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2010;:S91-S91

Professor Geo von Krogh Obituary
Lacey Cjn, Wikstrom A, Sandstrom E, Ruden Ak, Dillner J
SEXUALLY TRANSMITTED INFECTIONS 2010;86(2):155-155

Prospective study of human papillomavirus and risk of cervical adenocarcinoma
Dahlstrom La, Ylitalo N, Sundstrom K, Palmgren J, Ploner A, Eloranta S, et al
International journal of cancer 2010;127(8):1923-30

Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix
Sundstrom K, Eloranta S, Sparen P, Arnheim Dahlstrom L, Gunnell A, Lindgren A, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(10):2469-78

The interface of population-based cancer registries and biobanks in etiological and clinical research--current and future perspectives
Andersson K, Bray F, Arbyn M, Storm H, Zanetti R, Hallmans G, et al
Acta oncologica (Stockholm, Sweden) 2010;49(8):1227-34

Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples
Ekstrom J, Forslund O, Dillner J
Virology 2010;397(2):331-6

Validation of multiplexed human papillomavirus serology using pseudovirions bound to heparin-coated beads
Faust H, Knekt P, Forslund O, Dillner J
The Journal of general virology 2010;91(Pt 7):1840-8

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions
Kjaer Sk, Sigurdsson K, Iversen Oe, Hernandez-avila M, Wheeler Cm, Perez G, et al
Cancer prevention research (Philadelphia, Pa.) 2009;2(10):868-78

Decrease in GAD-65, IA-2 and insulin autoantibodies during non-diabetic pregnancy
Lindehammer Sr, Hansson I, Midberg B, Ivarsson Sa, Lynch K, Dillner J, et al
DIABETOLOGIA 2009;:S113-S114

Editorial
Hemminki K, Dillner J
International journal of cancer 2009;125(8):vii-

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening
Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al
Journal of the National Cancer Institute 2009;101(2):88-99

Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study
Holl K, Lundin E, Surcel Hm, Grankvist K, Koskela P, Dillner J, et al
International journal of cancer 2009;124(12):2923-8

EUROCOURSE: towards optimisation of the use of cancer registries for scientific excellence in cancer research in Europe: an FP7 ERA-net project
Coebergh J, Van Den Hurk Cjg, Storm Hh, Zanetti R, Comber H, Antilla A, et al
EJC SUPPLEMENTS 2009;7(2):201-202

EUROGIN 2008 roadmap on cervical cancer prevention
Franceschi S, Cuzick J, Herrero R, Dillner J, Wheeler Cm
International journal of cancer 2009;125(10):2246-55

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
Olsson Se, Kjaer Sk, Sigurdsson K, Iversen Oe, Hernandez-avila M, Wheeler Cm, et al
Human vaccines 2009;5(10):696-704

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Meijer Cj, Berkhof J, Castle Pe, Hesselink At, Franco El, Ronco G, et al
International journal of cancer 2009;124(3):516-20

H-pylori Seropositivity Before Age 40 and Subsequent Risk of Stomach Cancer: A Glimpse of the True Relationship?
Persson C, Jia Yb, Pettersson H, Dillner J, Ye Wm
GASTROENTEROLOGY 2009;136(5):A150-A150

Introduction of human papillomavirus (HPV) vaccination in Sweden
Tegnell A, Dillner J, Andrae B
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2009;14(6):-

Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks
Kapeu As, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, et al
American journal of epidemiology 2009;169(4):480-8

Male circumcision and serologically determined human papillomavirus infection in a birth cohort
Dickson Np, Ryding J, Van Roode T, Paul C, Herbison P, Dillner J, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):177-83

Maternal smoking during pregnancy and testicular cancer in the sons: a nested case-control study and a meta-analysis
Tuomisto J, Holl K, Rantakokko P, Koskela P, Hallmans G, Wadell G, et al
European journal of cancer (Oxford, England : 1990) 2009;45(9):1640-8

Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus
Soderlund-strand A, Carlson J, Dillner J
Journal of clinical microbiology 2009;47(3):541-6

No risk of maternal EBV infection for childhood leukemia
Tedeschi R, Luostarinen T, Marus A, Bzhalava D, Ogmundsdottir Hm, Dillner J, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(10):2790-2

Penile cancer: epidemiology, pathogenesis and prevention
Bleeker Mc, Heideman Da, Snijders Pj, Horenblas S, Dillner J, Meijer Cj
World journal of urology 2009;27(2):141-50

Post-vaccination HPV surveillance
Dillner J
EJC SUPPLEMENTS 2009;7(2):59-59

Risk of invasive cervical cancer in relation to management of abnormal Pap smear results
Silfverdal L, Kemetli L, Andrae B, Sparen P, Ryd W, Dillner J, et al
American journal of obstetrics and gynecology 2009;201(2):188.e1-7

SPECIAL SECTION ON INFECTION, HOST IMMUNITY, AND CANCER
Hemminki K, Dillner J
INTERNATIONAL JOURNAL OF CANCER 2009;125(8):VII-VII

Staphylococcus aureus and squamous cell carcinoma of the skin
Kullander J, Forslund O, Dillner J
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):472-8

The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma
Vasiljevic N, Andersson K, Bjelkenkrantz K, Kjellstrom C, Mansson H, Nilsson E, et al
International journal of cancer 2009;124(10):2361-6

The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24
Majewski S, Bosch Fx, Dillner J, Iversen Oe, Kjaer Sk, Munoz N, et al
Journal of the European Academy of Dermatology and Venereology : JEADV 2009;23(10):1147-55

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years
Brown Dr, Kjaer Sk, Sigurdsson K, Iversen Oe, Hernandez-avila M, Wheeler Cm, et al
The Journal of infectious diseases 2009;199(7):926-35

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years
Wheeler Cm, Kjaer Sk, Sigurdsson K, Iversen Oe, Hernandez-avila M, Perez G, et al
The Journal of infectious diseases 2009;199(7):936-44

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
Arbyn M, Martin-hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J
Journal of cellular and molecular medicine 2009;13(4):648-59

Validity of maternal genotypes in DNA from archival pregnancy serum samples
Ivarsson Mi, Dillner J, Carlson J
Clinical chemistry 2009;55(4):842-3

A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage
Bjerre P, Silfverdal L, Dillner L, Hagmar B, Edvardsson H, Dillner J, et al
American journal of obstetrics and gynecology 2008;199(1):24.e1-7

Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers
Reuschenbach M, Waterboer T, Wallin Kl, Einenkel J, Dillner J, Hamsikova E, et al
International journal of cancer 2008;123(11):2626-31

[Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project]
Sturegard E, Johnsson A, Gustafsson E, Dillner J
Läkartidningen 2008;105(50):3648-50

Cost-effectiveness of primary cytology and HPV DNA cervical screening
Bistoletti P, Sennfalt K, Dillner J
International journal of cancer 2008;122(2):372-6

Cutaneous human papillomavirus 88: remarkable differences in viral load
Kullander J, Handisurya A, Forslund O, Geusau A, Kirnbauer R, Dillner J
International journal of cancer 2008;122(2):477-80

Differences in transcriptional activity of cutaneous human papillomaviruses
Vasiljevic N, Nielsen L, Doherty G, Dillner J, Forslund O, Norrild B
Virus research 2008;137(2):213-9

Extremely high viral loads of HPV26 and HPV88 in squamous cell carcinomas (SCC) of the nail unit in an HIV-immunosuppressed patient
Handisurya A, Kullander J, Schellenbacher C, Forslund O, Dillner J, Kirnbauer R
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2008;:S194-S194

Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis
Vasiljevic N, Hazard K, Dillner J, Forslund O
The Journal of general virology 2008;89(Pt 10):2467-74

High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry
Soderlund-strand A, Dillner J, Carlson J
Clinical chemistry 2008;54(1):86-92

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
Joura Ea, Kjaer Sk, Wheeler Cm, Sigurdsson K, Iversen Oe, Hernandez-avila M, et al
Vaccine 2008;26(52):6844-51

Human papillomavirus and papanicolau tests to screen for cervical cancer (vol 357, pg 1589, 2007)
Naucler P, Ryd W, Tornberg S, Strand A, Tg W, Elfgren K, et al
NEW ENGLAND JOURNAL OF MEDICINE 2008;359(15):1637-1637

Human Papillomavirus (HPV) 26 and HPV 88 replicate to extremely high levels in squamous cell carcinomas (SCC) of the nail unit in anHIV-immunosuppressed patient
Handisurya A, Kullander J, Forslund O, Rieger A, Geusau A, Stingl G, et al
EXPERIMENTAL DERMATOLOGY 2008;17(3):274-274

Infection with Parvovirus B19 and Herpes viruses in early pregnancy and risk of second trimester miscarriage or very preterm birth
Johansson S, Buchmayer S, Harlid S, Iliadou A, Sjoholm M, Grillner L, et al
Reproductive toxicology (Elmsford, N.Y.) 2008;26(3-4):298-302

JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
Verbeeck J, Van Assche G, Ryding J, Wollants E, Rans K, Vermeire S, et al
Gut 2008;57(10):1393-7

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Dillner J, Rebolj M, Birembaut P, Petry Ku, Szarewski A, Munk C, et al
BMJ (Clinical research ed.) 2008;337():a1754-

Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring: a nested case-control study
Holl K, Surcel Hm, Koskela P, Dillner J, Hallmans G, Wadell G, et al
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2008;116(9):816-22

Maternal smoking during pregnancy, and testicular cancer in the offspring
Tuomisto J, Holl K, Rantakokko P, Koskela P, Hallmans G, Wadell G, et al
TOXICOLOGY LETTERS 2008;:S163-S163

Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry
Sjoholm Mi, Dillner J, Carlson J
Journal of clinical microbiology 2008;46(2):540-5

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries
Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand Mh, et al
Vaccine 2008;26 Suppl 10():K29-41

Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden
Andrae B, Kemetli L, Sparen P, Silfverdal L, Strander B, Ryd W, et al
Journal of the National Cancer Institute 2008;100(9):622-9

Seroepidemiology as basis for design of a human papillomavirus vaccination program
Ryding J, French Km, Naucler P, Barnabas Rv, Garnett Gp, Dillner J
Vaccine 2008;26(41):5263-8

Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions
Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, De Villiers Em, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(1):189-95

Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
Simen-kapeu A, Kataja V, Yliskoski M, Syrjanen K, Dillner J, Koskela P, et al
Scandinavian journal of infectious diseases 2008;40(9):745-51

Strengthening prevention programs to eliminate cervical cancer in the Nordic countries
Dillner L, Pagliusi S, Bray F, Lorincz A, Kjaer Sk, Anttila A, et al
Acta obstetricia et gynecologica Scandinavica 2008;87(5):489-98

Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring
Tedeschi R, Bloigu A, Ogmundsdottir Hm, Marus A, Dillner J, Depaoli P, et al
American journal of epidemiology 2007;165(2):134-7

Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study
Koskinen Wj, Brondbo K, Mellin Dahlstrand H, Luostarinen T, Hakulinen T, Leivo I, et al
Journal of cancer research and clinical oncology 2007;133(9):673-8

Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals
Okroj M, Spiller Ob, Korodi Z, Tedeschi R, Dillner J, Blom Am
Vaccine 2007;25(48):8102-9

Assessing quality and functionality of DNA from fresh and archival dried blood spots and recommendations for quality control guidelines
Sjoholm Mi, Dillner J, Carlson J
Clinical chemistry 2007;53(8):1401-7

Characterization of two novel cutaneous human papillomaviruses, HPV93 and HPV96
Vasiljevic N, Hazard K, Eliasson L, Ly H, Hunziker A, De Villiers Em, et al
The Journal of general virology 2007;88(Pt 5):1479-83

Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma
Forslund O, Iftner T, Andersson K, Lindelof B, Hradil E, Nordin P, et al
The Journal of infectious diseases 2007;196(6):876-83

Cutaneous human papillomaviruses persist on healthy skin
Hazard K, Karlsson A, Andersson K, Ekberg H, Dillner J, Forslund O
The Journal of investigative dermatology 2007;127(1):116-9

Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles
Ryding J, Dahlberg L, Wallen-ohman M, Dillner J
The Journal of general virology 2007;88(Pt 3):792-802

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
Ault Ka, Future Ii Study Group
Lancet (London, England) 2007;369(9576):1861-8

Ethical framework for previously collected biobank samples
Helgesson G, Dillner J, Carlson J, Bartram Cr, Hansson Mg
Nature biotechnology 2007;25(9):973-6

HPV26 and HPV88 infections are carcinogenic in immunosuppression causing squamous cell carcinoma of the nail unit
Handisurya A, Kullander J, Forslund O, Rieger A, Bankier A, Koller A, et al
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2007;:S75-S75

HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study
Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Hansson Bg, et al
British journal of cancer 2007;97(1):129-32

Human papillomavirus and Papanicolaou tests to screen for cervical cancer
Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al
The New England journal of medicine 2007;357(16):1589-97

Human papillomavirus subtypes are not uncommon
Hazard K, Andersson K, Dillner J, Forslund O
Virology 2007;362(1):6-9

Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer
Tuohimaa P, Tenkanen L, Syvala H, Lumme S, Hakulinen T, Dillner J, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(2):302-7

In vivo and in vitro intragenomic rearrangement of TT viruses
Leppik L, Gunst K, Lehtinen M, Dillner J, Streker K, De Villiers Em
Journal of virology 2007;81(17):9346-56

No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden
Lundstig A, Dejmek A, Eklund C, Filinic I, Dillner J
Anticancer research 2007;27(6B):4159-61

No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus
Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi Rp, Gislefoss Re, et al
International journal of cancer 2007;121(5):1098-102

Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers
Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, et al
Acta oncologica (Stockholm, Sweden) 2007;46(3):286-307

Population-based study of screening test performance indices of three human papillomavirus DNA tests
Wahlstrom C, Iftner T, Dillner J, Dillner L, Swedescreen Study Group
Journal of medical virology 2007;79(8):1169-75

Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection
Future Ii Study Group
The Journal of infectious diseases 2007;196(10):1438-46

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Future Ii Study Group
The New England journal of medicine 2007;356(19):1915-27

Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening
Arbyn M, Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;38(3):189-97

Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: nested case-control study
Naucler P, Chen Hc, Persson K, You Sl, Hsieh Cy, Sun Ca, et al
The Journal of general virology 2007;88(Pt 3):814-22

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
French Km, Barnabas Rv, Lehtinen M, Kontula O, Pukkala E, Dillner J, et al
British journal of cancer 2007;96(3):514-8

Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination
Dillner J, Arbyn M, Dillner L
Clinical and experimental immunology 2007;148(2):199-207

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening
Davies P, Arbyn M, Dillner J, Kitchener Hc, Meijer Cj, Ronco G, et al
International journal of cancer 2006;118(4):791-6

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies
International Collaboration Of Epidemiological Studies Of Cervical Cancer, Appleby P, Beral V, Berrington De Gonzalez A, Colin D, Franceschi S, et al
International journal of cancer 2006;118(6):1481-95

Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update
Pagliusi Sr, Dillner J, Pawlita M, Quint Wg, Wheeler Cm, Ferguson M
Vaccine 2006;24 Suppl 3():S3/193-200

Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
Lehtinen M, Herrero R, Mayaud P, Barnabas R, Dillner J, Paavonen J, et al
Vaccine 2006;24 Suppl 3():S3/233-41

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses
Arbyn M, Sasieni P, Meijer Cj, Clavel C, Koliopoulos G, Dillner J
Vaccine 2006;24 Suppl 3():S3/78-89

Clinical applications of HPV testing: A summary of meta-analyses
Arbyn M, Sasieni P, Meijer Cjlm, Clavel C, Koliopoulos G, Dillner J
VACCINE 2006;:78-89

Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe
Soldan K, Dillner J
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2006;11(11):E061123.3-

Detection of adeno-associated virus type 2 genome in cervical carcinoma
Zheng By, Li Xd, Wiklund F, Chowdhry S, Angstrom T, Hallmans G, et al
British journal of cancer 2006;94(12):1913-7

Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Västerbotten County, Sweden
Tedeschi R, Bidoli E, Agren A, Hallmans G, Wadell G, De Paoli P, et al
Journal of medical virology 2006;78(3):372-8

Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients
Zheng B, Wiklund F, Gharizadeh B, Sadat M, Gambelunghe G, Hallmans G, et al
Anticancer research 2006;26(5B):3669-74

International Standard reagents for harmonization of HPV serology and DNA assays - an update
Pagliusi Sr, Dillner J, Pawlita M, Quint Wgv, Wheeler Cm, Ferguson M
VACCINE 2006;:193-200

Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses
Ferguson M, Heath A, Johnes S, Pagliusi S, Dillner J, Collaborative Study Participants
International journal of cancer 2006;118(6):1508-14

Serological diagnosis of human polyomavirus infection
Lundstig A, Dillner J
Advances in experimental medicine and biology 2006;577():96-101

Should donors be allowed to give broad consent to future biobank research?
Hansson Mg, Dillner J, Bartram Cr, Carlson Ja, Helgesson G
The Lancet. Oncology 2006;7(3):266-9

Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
Lehtinen M, Herrero R, Mayaud P, Barnabas R, Dillner J, Paavonen J, et al
VACCINE 2006;:233-241

Subtype HPV38b[FA125] demonstrates heterogeneity of human papillomavirus type 38
Hazard K, Eliasson L, Dillner J, Forslund O
International journal of cancer 2006;119(5):1073-7

[Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools]
Dillner J, Andrae B, Westermark B
Läkartidningen 2006;103(44):3377-9

Abstract II: No difference in JCV or BKV seroprevalence between colon cancer patients and controls
Lundstig A, Stattin P, Persson K, Sasnauskas K, Dillner J
JOURNAL OF NEUROVIROLOGY 2005;:105-105

Abstract I: Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles
Lundstig A, Eliasson L, Lehtinen M, Sasnauskas K, Koskela P, Dillner J
JOURNAL OF NEUROVIROLOGY 2005;:104-104

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia
Arnheim L, Dillner J, Sanjeevi Cb
Tissue antigens 2005;65(3):252-9

[Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial]
Bistoletti P, Ellstrom A, Dillner J, Sennfalt K, Sparen P, Strander B
Läkartidningen 2005;102(24-25):1874-6

Chlamydial antibodies and risk of prostate cancer
Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss Re, Hallmans G, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):385-9

Chlamydia trachomatis infection and persistence of human papillomavirus
Silins I, Ryd W, Strand A, Wadell G, Tornberg S, Hansson Bg, et al
International journal of cancer 2005;116(1):110-5

Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence
Arbyn M, Paraskevaidis E, Martin-hirsch P, Prendiville W, Dillner J
Gynecologic oncology 2005;99(3 Suppl 1):S7-11

Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence
Elfgren K, Rylander E, Radberg T, Strander B, Strand A, Paajanen K, et al
American journal of obstetrics and gynecology 2005;193(3 Pt 1):650-7

Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia
Soderlund-strand A, Rymark P, Andersson P, Dillner J, Dillner L
Journal of clinical microbiology 2005;43(7):3260-6

Comparison of archival plasma and formalin-fixed paraffin-embedded tissue for genotyping in hepatocellular carcinoma
Sjoholm Mi, Hoffmann G, Lindgren S, Dillner J, Carlson J
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):251-5

Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA
Rommel O, Dillner J, Fligge C, Bergsdorf C, Wang X, Selinka Hc, et al
Journal of medical virology 2005;75(1):114-21

Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology
Wang X, Sapp M, Christensen Nd, Dillner J
The Journal of general virology 2005;86(Pt 1):65-73

Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study
Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(12):2952-5

Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
Tedeschi R, Luostarinen T, De Paoli P, Gislefoss Re, Tenkanen L, Virtamo J, et al
British journal of cancer 2005;93(7):834-7

Maternal human polyomavirus infection and risk of neuroblastoma in the child
Stolt A, Kjellin M, Sasnauskas K, Luostarinen T, Koskela P, Lehtinen M, et al
International journal of cancer 2005;113(3):393-6

No serological evidence of association between prostate cancer and infection with herpes simplex virus type 2 or human herpesvirus type 8: a nested case-control study
Korodi Z, Wang X, Tedeschi R, Knekt P, Dillner J
The Journal of infectious diseases 2005;191(12):2008-11

Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles
Lundstig A, Eliasson L, Lehtinen M, Sasnauskas K, Koskela P, Dillner J
The Journal of general virology 2005;86(Pt 6):1703-8

Toward "serolomics": papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysis
Dillner J
Clinical chemistry 2005;51(10):1768-9

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study
Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L, et al
Neurology 2004;62(12):2277-82

A population-based study of cervical carcinoma and HPV infection in Latvia
Silins I, Wang X, Tadesse A, Jansen Ku, Schiller Jt, Avall-lundqvist E, et al
Gynecologic oncology 2004;93(2):484-92

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries
Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, et al
International journal of cancer 2004;108(1):104-8

Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?
Dillner J, Brown Dr
Expert reviews in molecular medicine 2004;6(9):1-21

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study
Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, et al
International journal of cancer 2004;108(3):418-24

High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors
Forslund O, Lindelof B, Hradil E, Nordin P, Stenquist B, Kirnbauer R, et al
The Journal of investigative dermatology 2004;123(2):388-94

HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses
Rollman E, Arnheim L, Collier B, Oberg D, Hall H, Klingstrom J, et al
Virology 2004;322(1):182-9

Human papillomavirus genotypes in cervical cancers in Mozambique
Naucler P, Da Costa Fm, Ljungberg O, Bugalho A, Dillner J
The Journal of general virology 2004;85(Pt 8):2189-90

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study (vol 87, pg 61, 2002)
Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss Re, Jellum E, et al
BRITISH JOURNAL OF CANCER 2004;91(6):1226-1226

Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri
Luostarinen T, Lehtinen M, Bjorge T, Abeler V, Hakama M, Hallmans G, et al
European journal of cancer (Oxford, England : 1990) 2004;40(7):1058-65

Metabolism of 25-hydroxyvitamin D-3 may explain the U-shaped risk curve for prostate cancer
Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, et al
INTERNATIONAL JOURNAL OF CANCER 2004;111(3):469-469

Re: Have we resolved how to triage equivocal cervical cytology?
Arbyn M, Dillner J, Van Ranst M, Buntinx F, Martin-hirsch P, Paraskevaidis E
Journal of the National Cancer Institute 2004;96(18):1401-2

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia
Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-hirsch P, Dillner J
Journal of the National Cancer Institute 2004;96(4):280-93

Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later
Lehtinen M, Pawlita M, Zumbach K, Lie K, Hakama M, Jellum E, et al
American journal of obstetrics and gynecology 2003;188(1):49-55

Letter to the editor - Reply
Silins I, Avall-lundqvist E, Dillner J, Frankendal B
GYNECOLOGIC ONCOLOGY 2003;89(2):339-339

Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11
Wang X, Wang Z, Christensen Nd, Dillner J
Virology 2003;311(1):213-21

Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring
Lehtinen M, Koskela P, Ogmundsdottir Hm, Bloigu A, Dillner J, Gudnadottir M, et al
American journal of epidemiology 2003;158(3):207-13

Moderate variation of the oncogenic potential among high-risk human papillomavirus types in gynecologic patients with cervical abnormalities
Szoke K, Sapy T, Krasznai Z, Hernadi Z, Szladek G, Veress G, et al
Journal of medical virology 2003;71(4):585-92

Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case-control study
Adami Ho, Kuper H, Andersson So, Bergstrom R, Dillner J
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(9):872-5

Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites
Van Doornum Gj, Korse Cm, Buning-kager Jc, Bonfrer Jm, Horenblas S, Taal Bg, et al
British journal of cancer 2003;88(7):1095-100

Seroepidemiology of the human polyomaviruses
Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J
The Journal of general virology 2003;84(Pt 6):1499-504

[Testing HPV vaccine is an ethical dilemma. Can we afford not to offer vaccination against an infection which is a cause of cancer?]
Dillner J
Läkartidningen 2003;100(43):3390-1

Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland
Laukkanen P, Koskela P, Pukkala E, Dillner J, Laara E, Knekt P, et al
The Journal of general virology 2003;84(Pt 8):2105-9

A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma
Wallin Kl, Wiklund F, Luostarinen T, Angstrom T, Anttila T, Bergman F, et al
International journal of cancer 2002;101(4):371-4

A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas
Sigstad E, Lie Ak, Luostarinen T, Dillner J, Jellum E, Lehtinen M, et al
British journal of cancer 2002;87(2):175-80

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study
Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, et al
International journal of cancer 2002;99(1):124-9

Clustering of seropositivities for sexually transmitted infections
Silins I, Tedeschi Rm, Kallings I, Dillner J
Sexually transmitted diseases 2002;29(4):207-11

Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients
Silins I, Avall-lundqvist E, Tadesse A, Jansen Ku, Stendahl U, Lenner P, et al
Gynecologic oncology 2002;85(2):333-8

Evaluation of cost-precision rations of different strategies for ELISA measurement of serum antibody levels
Grabowska K, Wang X, Jacobsson A, Dillner J
Journal of immunological methods 2002;271(1-2):1-15

Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries
Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, et al
American journal of epidemiology 2002;156(8):687-92

HPV testing in cervical cancer
Dillner J
INTERNATIONAL JOURNAL OF CANCER 2002;:31-32

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss Re, Jellum E, et al
British journal of cancer 2002;87(1):61-4

Laboratory diagnosis of human herpesvirus 8 infection in humans
Tedeschi R, Dillner J, De Paoli P
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002;21(12):831-44

Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women
Forslund O, Antonsson A, Edlund K, Van Den Brule Aj, Hansson Bg, Meijer Cj, et al
Journal of medical virology 2002;66(4):535-41

Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. (vol 66, pg 535, 2002)
Forslund O, Antonsson A, Edlund K, Van Den Brule Ajc, Hansson Bg, Meijer Cjlm, et al
JOURNAL OF MEDICAL VIROLOGY 2002;67(3):467-467

Preventive human papillomavirus vaccination
Lehtinen M, Dillner J
Sexually transmitted infections 2002;78(1):4-6

Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia
Elfgren K, Jacobs M, Walboomers Jm, Meijer Cj, Dillner J
Obstetrics and gynecology 2002;100(5 Pt 1):965-71

Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes
Ghaderi M, Wallin Kl, Wiklund F, Zake Ln, Hallmans G, Lenner P, et al
International journal of cancer 2002;100(6):698-701

[The new biobank law accepted: a unique chance of improvement]
Dillner J
Läkartidningen 2002;99(24):2774-6

[The survey of Danish biobanks suggests a "drop-out" registry]
Dillner J
Läkartidningen 2002;99(44):4384-5

Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom
Scott Dr, Hagmar B, Maddox P, Hjerpe A, Dillner J, Cuzick J, et al
Cancer 2002;96(1):14-20

A prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myeloma
Tedeschi R, Kvarnung M, Knekt P, Schulz Tf, Szekely L, De Paoli Pd, et al
British journal of cancer 2001;84(1):122-5

Chlamydia trachomatis and cervical squamous cell carcinoma - Reply
Anttila T, Koskela P, Lehtimen M, Dillner J, Paavonen J
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2001;285(13):1705-1706

[How to handle biological material? New legislation concerning biobanks in Finland]
Dillner J
Läkartidningen 2001;98(41):4478-9

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck
Mork J, Lie Ak, Glattre E, Hallmans G, Jellum E, Koskela P, et al
The New England journal of medicine 2001;344(15):1125-31

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck - Reply
Mork J, Lehtinen M, Dillner J
NEW ENGLAND JOURNAL OF MEDICINE 2001;345(5):377-377

Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction
Lehtinen M, Luukkaala T, Wallin Kl, Paavonen J, Thoresen S, Dillner J, et al
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;22(1):117-24

Immunity to oncogenic human papillomaviruses
Konya J, Dillner J
Advances in cancer research 2001;82():205-38

Poor antibody response against human papillomavirus in adult-onset laryngeal papillomatosis
Aaltonen Lm, Auvinen E, Dillner J, Lehtinen M, Paavonen J, Rihkanen H, et al
Journal of medical microbiology 2001;50(5):468-71

Primary screening for human papillomavirus infection
Dillner J
Best practice & research. Clinical obstetrics & gynaecology 2001;15(5):743-57

Response to association between invasive squamous cell carcinoma and lichen sclerosus et atrophicus
Dillner J
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY 2001;35(6):435-436

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine
Harro Cd, Pang Yy, Roden Rb, Hildesheim A, Wang Z, Reynolds Mj, et al
Journal of the National Cancer Institute 2001;93(4):284-92

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, et al
JAMA 2001;285(1):47-51

Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer
Ghaderi M, Nikitina Zake L, Wallin K, Wiklund F, Hallmans G, Lenner P, et al
Human immunology 2001;62(10):1153-8

Vaccinating women against premature death: summary of an International Workshop, Helsinki, Finland, 10.01.2000
Lehtinen M, Dillner J, Paavonen J
Vaccine 2001;19(11-12):1347-52

Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma
Tedeschi R, Enbom M, Bidoli E, Linde A, De Paoli P, Dillner J
Journal of clinical microbiology 2001;39(12):4269-73

A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples
Nelson Jh, Hawkins Ga, Edlund K, Evander M, Kjellberg L, Wadell G, et al
Journal of clinical microbiology 2000;38(2):688-95

A population-based five-year follow-up study of cervical human papillomavirus infection
Elfgren K, Kalantari M, Moberger B, Hagmar B, Dillner J
American journal of obstetrics and gynecology 2000;183(3):561-7

Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination
Kibur M, Af Geijerstamm V, Pukkala E, Koskela P, Luostarinen T, Paavonen J, et al
Sexually transmitted infections 2000;76(1):13-7

Cervical cancer screening in Sweden
Dillner J
European journal of cancer (Oxford, England : 1990) 2000;36(17):2255-9

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer
Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, et al
International journal of cancer 2000;85(1):35-9

Correlates of the spread of human papillomavirus infection
Silins I, Kallings I, Dillner J
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(9):953-9

Epidemiology of human papillomavirus infection
Dillner J, Meijer Cj, Von Krogh G, Horenblas S
Scandinavian journal of urology and nephrology. Supplementum 2000;(205):194-200

Etiology of squamous cell carcinoma of the penis
Dillner J, Von Krogh G, Horenblas S, Meijer Cj
Scandinavian journal of urology and nephrology. Supplementum 2000;(205):189-93

Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser
Kjellberg L, Wadell G, Bergman F, Isaksson M, Angstrom T, Dillner J
American journal of obstetrics and gynecology 2000;183(5):1238-42

Seroepidemiology of human papillomavirus type 73: a sexually transmitted low-risk virus
Wallin Kl, Van Doornum Gj, Andersson-ellstrom A, Kallings I, Wiklund F, Hallmans G, et al
International journal of cancer 2000;85(3):353-7

Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections among women
Tedeschi R, Caggiari L, Silins I, Kallings I, Andersson-ellstrom A, De Paoli P, et al
International journal of cancer 2000;87(2):232-5

Seropositivity to multiple sexually transmitted infections is not common
Kibur M, Koskela P, Dillner J, Leinikki P, Saikku P, Lehtinen M, et al
Sexually transmitted diseases 2000;27(8):425-30

Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection
Kjellberg L, Hallmans G, Ahren Am, Johansson R, Bergman F, Wadell G, et al
British journal of cancer 2000;82(7):1332-8

Squamous cell carcinoma of the penis: premalignant lesions
Horenblas S, Von Krogh G, Cubilla Al, Dillner J, Meijer Cj, Hedlund Po
Scandinavian journal of urology and nephrology. Supplementum 2000;(205):187-8

Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection
Dillner J
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2000;19(1-2):7-23

Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden
Ghaderi M, Nikitina L, Peacock Cs, Hjelmstrom P, Hallmans G, Wiklund F, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(10):1067-70

Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids
Wang Zh, Kjellberg L, Abdalla H, Wiklund F, Eklund C, Knekt P, et al
The Journal of infectious diseases 2000;181(2):456-62

High risk genital papillomavirus infections are not spread vertically
Dillner J, Andersson-ellstrom A, Hagmar B, Schiller J
Reviews in medical virology 1999;9(1):23-9

A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children
Af Geijersstam V, Eklund C, Wang Z, Sapp M, Schiller Jt, Dillner J, et al
International journal of cancer 1999;80(4):489-93

Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden
Lagergren J, Wang Z, Bergstrom R, Dillner J, Nyren O
Journal of the National Cancer Institute 1999;91(2):156-62

Human serum antibodies to a major defined epitope of human herpesvirus 8 small viral capsid antigen
Tedeschi R, De Paoli P, Schulz Tf, Dillner J
The Journal of infectious diseases 1999;179(4):1016-20

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16
Bontkes Hj, De Gruijl Td, Walboomers Jm, Schiller Jt, Dillner J, Helmerhorst Tj, et al
The Journal of general virology 1999;80 ( Pt 2)():409-17

Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: interaction with HPV seropositivity
Lehtinen M, Luostarinen T, Youngman Ld, Anttila T, Dillner J, Hakulinen T, et al
Nutrition and cancer 1999;34(2):229-34

MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia
Ghaderi M, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Dillner J, et al
Human immunology 1999;60(10):970-3

No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11
Luostarinen T, Af Geijersstam V, Bjorge T, Eklund C, Hakama M, Hakulinen T, et al
International journal of cancer 1999;80(6):818-22

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison
Jacobs Mv, Snijders Pj, Voorhorst Fj, Dillner J, Forslund O, Johansson B, et al
Journal of clinical pathology 1999;52(7):498-503

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison (vol 52, pg 498, 1999)
Jacobs Mv, Snijders Pjf, Voorhorst Fj, Dillner J, Forslund O, Johansson B, et al
JOURNAL OF CLINICAL PATHOLOGY 1999;52(10):790-790

Salivary sIgA response in HIV-1 infection
Skott P, Lucht E, Julander I, Dillner J, Bjorling E
Journal of acquired immune deficiency syndromes (1999) 1999;21(2):73-80

Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis
Silins I, Wang Z, Avall-lundqvist E, Frankendal B, Vikmanis U, Sapp M, et al
The Journal of general virology 1999;80 ( Pt 11)():2931-6

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
Lenner P, Wiklund F, Emdin So, Arnerlov C, Eklund C, Hallmans G, et al
British journal of cancer 1999;79(5-6):927-32

Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study
Kjellberg L, Wang Z, Wiklund F, Edlund K, Angstrom T, Lenner P, et al
The Journal of general virology 1999;80 ( Pt 2)():391-8

The serological response to papillomaviruses
Dillner J
Seminars in cancer biology 1999;9(6):423-30

Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer
Wallin Kl, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, et al
The New England journal of medicine 1999;341(22):1633-8

A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia
Kjellberg L, Wiklund F, Sjoberg I, Wadell G, Angstrom T, Dillner J, et al
American journal of obstetrics and gynecology 1998;179(6 Pt 1):1497-502

Can cervical cancer screening programs be improved by incorporating screening for human papillomavirus infection?
Dillner J
CANCER JOURNAL 1998;11(6):272-276

Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis
Olsen Ao, Dillner J, Skrondal A, Magnus P
Epidemiology (Cambridge, Mass.) 1998;9(3):346-9

Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III
Olsen Ao, Orstavik I, Dillner J, Vestergaard Bf, Magnus P
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1998;106(3):417-24

Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection
Van Doornum G, Prins M, Andersson-ellstrom A, Dillner J
Sexually transmitted infections 1998;74(5):354-60

Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer
Dillner J, Knekt P, Boman J, Lehtinen M, Af Geijersstam V, Sapp M, et al
International journal of cancer 1998;75(4):564-7

Stability over time of serum antibody levels to human papillomavirus type 16
Af Geijersstam V, Kibur M, Wang Z, Koskela P, Pukkala E, Schiller J, et al
The Journal of infectious diseases 1998;177(6):1710-4

Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989
Af Geijersstam V, Wang Z, Lewensohn-fuchs I, Eklund C, Schiller Jt, Forsgren M, et al
International journal of cancer 1998;76(3):341-4

A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera
Wang Z, Christensen N, Schiller Jt, Dillner J
The Journal of general virology 1997;78 ( Pt 9)():2209-15

Antibodies against human papillomavirus type 6 capsids are elevated in men with previous condylomas
Wikstrom A, Eklund C, Von Krogh G, Lidbrink P, Dillner J
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1997;105(11):884-8

A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway
Bjorge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, et al
Cancer research 1997;57(18):3989-92

Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions
Strickler Hd, Schiffman Mh, Eklund C, Glass Ag, Scott Dr, Sherman Me, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(3):183-8

Human papillomavirus antibody responses among patients with incident cervical carcinoma
Wang Z, Konya J, Avall-lundkvist E, Sapp M, Dillner J, Dillner L
Journal of medical virology 1997;52(4):436-40

Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein
Konya J, Eklund C, Af Geijersstam V, Yuan F, Stuber G, Dillner J
The Journal of general virology 1997;78 ( Pt 10)():2615-20

Primary induction of human cytotoxic lymphocytes against a synthetic peptide of the human immunodeficiency virus type 1 protease
Konya J, Stuber G, Bjorndal A, Fenyo Em, Dillner J
The Journal of general virology 1997;78 ( Pt 9)():2217-24

Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers
Bjorge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, et al
BMJ (Clinical research ed.) 1997;315(7109):646-9

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E, et al
Journal of the National Cancer Institute 1997;89(17):1293-9

Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA
Olsen Ao, Dillner J, Gjoen K, Magnus P
Genitourinary medicine 1997;73(2):131-5

[Sexuality and STD infections among teenage girls. "Unprotected sex" is common in spite of sufficient knowledge about the risks]
Andersson-ellstrom A, Dillner J, Hagmar B, Milsom I
Läkartidningen 1997;94(8):619-21

TNF-A11 allele increases the risk significantly for carcinoma cervix (CaCx) in DR15-DQ6 (B*0602) positive patients.
Sanjeevi Cb, Ghaderi M, Peacock Cs, Hjelmstrom P, Hallmans G, Wiklund F, et al
HUMAN IMMUNOLOGY 1997;:49-49

Antibody responses to defined epitopes in the Epstein-Barr virus BZLF1-encoded transactivator protein among human immunodeficiency virus-infected patients
Tedeschi R, Dillner J, De Paoli P
Clinical and diagnostic laboratory immunology 1996;3(3):363-4

A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix
Olsen Ao, Dillner J, Gjoen K, Sauer T, Orstavik I, Magnus P
International journal of cancer 1996;68(4):415-9

A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears
Chua Kl, Wiklund F, Lenner P, Angstrom T, Hallmans G, Bergman F, et al
International journal of cancer 1996;68(1):54-9

Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA
Wang Z, Hansson Bg, Forslund O, Dillner L, Sapp M, Schiller Jt, et al
Journal of clinical microbiology 1996;34(12):3056-62

Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study
Andersson-ellstrom A, Dillner J, Hagmar B, Schiller J, Sapp M, Forssman L, et al
Sexually transmitted diseases 1996;23(3):234-8

Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens
Elfgren K, Bistoletti P, Dillner L, Walboomers Jm, Meijer Cj, Dillner J
American journal of obstetrics and gynecology 1996;174(3):937-42

Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women
Sanjeevi Cb, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Angstrom T, et al
International journal of cancer 1996;68(4):409-14

HLA-DQ6 (B*0602) is associated with human pappiloma virus (HPV) type 18, 33 antibody negative carcinoma cervix (CaCx) patients.
Sanjeevi Cb, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Dillner J, et al
HUMAN IMMUNOLOGY 1996;:55-55

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study
Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R, et al
BMJ (Clinical research ed.) 1996;312(7030):537-9

Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior
Dillner J, Kallings I, Brihmer C, Sikstrom B, Koskela P, Lehtinen M, et al
The Journal of infectious diseases 1996;173(6):1394-8

Serum p53 accumulation and altered antibody responses to Epstein-Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin
Lehtinen T, Luostarinen T, Dillner J, Aromaa A, Hakama M, Hakulinen T, et al
British journal of haematology 1996;93(1):104-10

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies
Christensen Nd, Dillner J, Eklund C, Carter Jj, Wipf Gc, Reed Ca, et al
Virology 1996;223(1):174-84

A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles
Eklund C, Dillner J
Journal of virological methods 1995;53(1):11-23

Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer
Dillner J, Wiklund F, Lenner P, Eklund C, Frederiksson-shanazarian V, Schiller Jt, et al
International journal of cancer 1995;60(3):377-82

Association of serum antibodies against defined epitopes of human papillomavirus L1, E2, and E7 antigens and of HPV DNA with incident cervical cancer
Dillner L, Zellbi A, Avall-lundqvist E, Heino P, Eklund C, Pettersson Ca, et al
Cancer detection and prevention 1995;19(5):381-93

Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma
Heino P, Eklund C, Fredriksson-shanazarian V, Goldman S, Schiller Jt, Dillner J
Journal of the National Cancer Institute 1995;87(6):437-40

HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1
Stuber G, Dillner J, Modrow S, Wolf H, Szekely L, Klein G, et al
International immunology 1995;7(4):653-63

HPV-16 TRANSMISSION - REPLY
Anderssonellstrom A, Dillner J, Hagmar B, Schiller J, Forssman L
LANCET 1995;345(8943):197-198

Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles
Heino P, Dillner J, Schwartz S
Virology 1995;214(2):349-59

Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes
Heino P, Skyldberg B, Lehtinen M, Rantala I, Hagmar B, Kreider Jw, et al
The Journal of general virology 1995;76 ( Pt 5)():1141-53

Identification of human papillomavirus seroconversions
Wikstrom A, Van Doornum Gj, Quint Wg, Schiller Jt, Dillner J
The Journal of general virology 1995;76 ( Pt 3)():529-39

Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma
Cheng Hm, Foong Yt, Abusamah Aj, Dillner J, Sam Ck, Prasad U
Cancer immunology, immunotherapy : CII 1995;40(4):251-6

Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma
Dillner J, Knekt P, Schiller Jt, Hakulinen T
BMJ (Clinical research ed.) 1995;311(7016):1346-

Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection
Wikstrom A, Van Doornum Gj, Kirnbauer R, Quint Wg, Dillner J
Journal of medical virology 1995;46(4):368-74

SEROLOGY OF HUMAN PAPILLOMAVIRUS
Dillner J
CANCER JOURNAL 1995;8(5):264-269

Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervix
Lenner P, Dillner J, Wiklund F, Hallmans G, Stendahl U
Cancer immunology, immunotherapy : CII 1995;40(3):201-5

Strategies for global control of cervical cancer
Ponten J, Adami Ho, Bergstrom R, Dillner J, Friberg Lg, Gustafsson L, et al
International journal of cancer 1995;60(1):1-26

SURFACE-EXPOSED CRYPTIC LINEAR EPITOPES OF HUMAN PAPILLOMAVIRUS (HPV) TYPE-16
Dillner J, Heino P
JOURNAL OF CELLULAR BIOCHEMISTRY 1995;:300-300

The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes
Tedeschi R, Foong Yt, Cheng Hm, Depaoli P, Lehtinen T, Elfborg T, et al
The Journal of general virology 1995;76 ( Pt 6)():1393-400

Visa alla publikationer